These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7992527)

  • 21. [The bacterial associations in maxillofacial actinomycosis].
    Zhdanova LP; Robustova TG; Oleĭnik II; Ushakov AI; Stromilova LI
    Stomatologiia (Mosk); 1990; (4):35-8. PubMed ID: 2251694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 24. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
    Chernoglazova EM
    Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of acute cervicofacial cellulitis of dental origin. The value of antibiotic sensitivity tests in the treatment of cellulitis apropos of 31 cases].
    Ait-Belkacem M
    Rev Odontostomatol (Paris); 1985; 14(1):35-41. PubMed ID: 3866271
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of associative opportunistic flora in the development of odontogenic inflammatory diseases of the maxillofacial area].
    Chumakov AA; Mirinova LG; Zotova LA
    Stomatologiia (Mosk); 1991; (6):30-2. PubMed ID: 1803646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biology and treatment of odontogenic inflammatory processes in light of the latest views].
    Kepiński R
    Czas Stomatol; 1981 Jan; 34(1):27-31. PubMed ID: 7011691
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antibiotic resistance of the microflora from lesion foci in acute odontogenic osteomyelitis of the jaws].
    Semenchenko GI; Diachenko IuV; Mul'kevich VV
    Stomatologiia (Mosk); 1982; 61(1):45-7. PubMed ID: 6950563
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Tarasenko SV; Aleksashina IP; Agapov VS; Trukhina GM; Liapunov NA
    Stomatologiia (Mosk); 2000; 79(2):17-9. PubMed ID: 10812984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 35. [Microbiological studies in maxillofacial inflammations].
    Andrä A; Schmidt H; Naumann G
    Stomatol DDR; 1979 Feb; 29(2):81-5. PubMed ID: 287255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiseptics in the combined treatment of patients with perimaxillary abscesses and phlegmons].
    Biberman IaM; Starodubtsev VS; Shutova AP
    Stomatologiia (Mosk); 1996; 75(6):25-7. PubMed ID: 9214031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sensitivity of the intestinal microflora of patients to antimicrobial preparations studied in order to conduct rational antibiotic treatment].
    Korshunov VM; Sinitsyna NA; Levashev VS; Ginodman GA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):24-30. PubMed ID: 3716687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy of the eubiotic bifacide when used in the combined antibacterial therapy of newborn infants with infectious-inflammatory diseases].
    Kushnareva MV; Dement'eva GM; Chernonog IN; Frolova MI; Feklisova LV; Rebrova TN
    Antibiot Khimioter; 1996; 41(11):28-32. PubMed ID: 9214283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.